Imunon, Inc. (IMNN) Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Imunon, Inc. on May 12, 2026. The filing serves to announce the issuance of a press release detailing financial results for the quarter ended March 31, 2026. The company is incorporated in Delaware and trades on the Nasdaq Capital Market under the symbol IMNN.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the press release furnished as Exhibit 99.1, which is referenced but not included in the body of this 8-K document.
Material Changes
No material changes versus the prior comparable period are detailed in this filing. The document acts solely as a notification of the results announcement and the scheduled conference call.
Guidance, Outlook, and Risks
- Conference Call: Imunon announced a conference call held on May 12, 2026, to discuss Q1 2026 results and provide a business update. The call was broadcast live via the internet.
- Forward-Looking Statements: The referenced press release contains forward-looking statements involving risks and uncertainties that could cause actual results to differ materially from expectations.
- Legal Disclaimer: The information in this report and its exhibits is furnished and not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934. It shall not be incorporated by reference into other SEC filings.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated May 12, 2026) for specific Q1 2026 financial figures.
- Access the conference call recording or transcript for management commentary on the business update.
- Verify the company's cash position and runway given the lack of specific liquidity data in this summary filing.
- Check for any subsequent filings that may incorporate the forward-looking statements referenced in the cautionary note.